Home › Asset managers › Compare 2023-2024 › American Century vs ProShares
American Century 2023-2024 · ProShares 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 25,933 | 24,246 | 1,483 | 204 | 94.2% | 93.9% |
| Board proposals | 23,536 | 22,057 | 1,327 | 152 | 94.3% | 94.1% |
| E&S shareholder proposals | 397 | 245 | 117 | 35 | 67.7% | 65.9% |
| Other items | 2,000 | 1,944 | 39 | 17 | 98.0% | 97.6% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,479 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | ProShares |
|---|---|---|---|---|---|---|
| 1-800-FLOWERS.COM INC. | December 14, 2023 | To approve an amendment to the 2003 Long Term Incentive and Share Award Plan to increase the authorized shares. Compensation |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| AAON INC. | May 21, 2024 | Proposal to approve the Company's 2024 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 10 funds |
| AAON INC. | May 21, 2024 | Proposal to approve, on an advisory basis, a resolution on the compensation of AAON's named executive officers as set forth in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| AAR CORP. | September 19, 2023 | Approve an amendment to our stock plan Compensation |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| AARON'S COMPANY INC. | May 15, 2024 | Approval of an amendment and restatement of The Aaron's Company Inc. Amended and Restated 2020 Equity and Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| ABBOTT LABORATORIES | April 26, 2024 | Say on Pay - An Advisory Vote on the Approval of Executive Compensation Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 19 funds |
| ACACIA RESEARCH CORP. | May 21, 2024 | To approve the 2024 Acacia Research Corporation Stock Incentive Plan, which authorizes the issuance of a variety of equity awards, including stock options, restricted stock units, performance stock units and stock awards. Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| ACACIA RESEARCH CORP. | May 21, 2024 | To approve, on a non-binding, advisory basis, of the compensation of our named executive officers, as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2024 | To approve the Company's 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| ACCO BRANDS CORP. | May 21, 2024 | Approval, by non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| ACCURAY INC. | November 9, 2023 | To approve an amendment to our 2016 Equity Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| ACNB CORP. | May 7, 2024 | TO CONDUCT A NON-BINDING VOTE ON EXECUTIVE COMPENSATION. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| ADAPTHEALTH CORP. | June 20, 2024 | Amendment and Restatement of 2019 Stock Incentive Plan - To approve the amendment and restatement of the 2019 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| ADDUS HOMECARE CORP. | June 12, 2024 | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| ADEIA INC. | May 9, 2024 | To approve an Amended and Restated 2020 Equity Incentive Plan; and Compensation |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| ADEIA INC. | May 9, 2024 | To hold an advisory vote to approve the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| ADTRAN HOLDINGS INC. | May 8, 2024 | Approval of the ADTRAN Holdings, Inc. 2024 Employee Stock Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| ADVANTAGE SOLUTIONS INC. | May 29, 2024 | To approve, on an advisory (non-binding) basis, the compensation of Advantage Solutions Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| AES CORP. | April 25, 2024 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 17 funds |
| AFLAC INC. | May 6, 2024 | to consider the following non-binding advisory proposal: "Resolved, on an advisory basis, the shareholders of Aflac Incorporated approve the compensation of the named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and accompanying tables and narrative in the Notice of 2024 Annual Meeting of Shareholders and Proxy Statement" Say-on-Pay |
Board | For | AGAINST 14 funds |
FOR 17 funds |
| AGREE REALTY CORP. | May 23, 2024 | To approve the 2024 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| AGREE REALTY CORP. | May 23, 2024 | To approve, by non-binding vote, executive compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| AIA GROUP LTD. | May 24, 2024 | Elect Cesar Velasquez Purisima as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| AKERO THERAPEUTICS INC. | June 7, 2024 | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| ALAMOS GOLD INC. | May 23, 2024 | Elect Director David Fleck Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 1 fund |
| ALBEMARLE CORP. | May 7, 2024 | To approve the non-binding advisory resolution approving the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 20 funds |
| ALEXANDRIA REAL ESTATE EQUITIES INC. | May 14, 2024 | To consider and vote upon the amendment and restatement of the Company's Amended and Restated 1997 Stock Award and Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 15 funds |
| ALIGN TECHNOLOGY INC. | May 22, 2024 | ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 17 funds |
| ALKERMES PLC | May 31, 2024 | To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. Compensation |
Board | For | AGAINST 13 funds |
FOR 15 funds |
| ALLETE INC. | May 14, 2024 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 15 funds |
| ALLIENT INC. | May 8, 2024 | ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| ALLKEM LTD. | November 8, 2023 | Approve Grant of LTI Performance Rights to Martin Perez de Solay Compensation |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| ALLSTATE CORP (THE) | May 14, 2024 | Advisory vote to approve the compensation of the named executives. Say-on-Pay |
Board | For | AGAINST 19 funds |
FOR 16 funds |
| ALLY FINANCIAL INC. | May 7, 2024 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 7 funds |
| ALNYLAM PHARMACEUTICALS INC. | May 16, 2024 | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. Say-on-Pay |
Board | For | AGAINST 18 funds |
FOR 3 funds |
| ALPHA AND OMEGA SEMICONDUCTOR LTD. | November 10, 2023 | To approve an amendment and restatement of the Company's 2018 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 10 funds |
| ALPHA METALLURGICAL RESOURCES INC. | May 2, 2024 | Advisory approval of the Company's executive compensation as reported in the proxy statement for the annual meeting. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 10 funds |
| ALPHATEC HOLDINGS INC. | June 12, 2024 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| ALPHATEC HOLDINGS INC. | June 12, 2024 | To elect nine persons to our Board of Directors; Mortimer Berkowitz III Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 7 funds |
| ALTAIR ENGINEERING INC. | May 16, 2024 | To vote, on an advisory basis, on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| ALUMINA LTD. | May 28, 2024 | Approve Grant of Performance Rights to Mike Ferraro Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| ALX ONCOLOGY HOLDINGS INC. | June 12, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| ALX ONCOLOGY HOLDINGS INC. | June 12, 2024 | Election of Directors: Jason Lettmann Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 8 funds |
| ALX ONCOLOGY HOLDINGS INC. | June 12, 2024 | Election of Directors: Sophia Randolph, M.D., Ph.D. Director Elections |
Board | For | WITHHOLD 3 funds |
FOR 8 funds |
| AMERANT BANCORP INC. | May 8, 2024 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers - Say-on-Pay. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| AMEREN CORP. | May 9, 2024 | COMPANY PROPOSAL - ADVISORY APPROVAL OF COMPENSATION OF THE NAMED EXECUTIVE OFFICERS DISCLOSED IN THE PROXY STATEMENT. Say-on-Pay |
Board | Not determined | AGAINST 5 funds |
FOR 16 funds |
| AMERICAN AXLE & MANUFACTURING HLDGS INC. | May 2, 2024 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 10 funds |
| AMERICAN ELECTRIC POWER COMPANY INC. | April 23, 2024 | Approval of the American Electric Power System 2024 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 22 funds |
| AMERICAN FINANCIAL GROUP INC. | May 23, 2024 | Approval of the Amended and Restated 2015 Stock Incentive Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| AMERICAN STATES WATER CO. | May 21, 2024 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 15 funds |
| AMERICAN WOODMARK CORP. | August 24, 2023 | To approve the American Woodmark Corporation 2023 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| AMERIPRISE FINANCIAL INC. | April 24, 2024 | To approve the compensation of the named executive officers by a nonbinding advisory vote. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 17 funds |
| AMERIS BANCORP | June 6, 2024 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| AMICUS THERAPEUTICS INC. | June 6, 2024 | Approval of the Amended and Restated 2007 Equity Incentive Plan to add 7,000,000 shares to the equity pool. Compensation |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| AMKOR TECHNOLOGY INC. | May 14, 2024 | Election of Directors: Gil C. Tily Director Elections |
Board | For | FOR 14 funds |
WITHHOLD 17 funds |
| AMPHASTAR PHARMACEUTICALS INC. | June 3, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers; and Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 13 funds |
| AMPHENOL CORP. | May 16, 2024 | Advisory Vote to Approve Compensation of Named Executive Officers Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 19 funds |
| AMPLIFY ENERGY CORP. | May 15, 2024 | To approve the Amplify Energy Corp. 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| AMPLITUDE INC. | June 11, 2024 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| AMYLYX PHARMACEUTICALS INC. | June 6, 2024 | To approve, on a non-binding, advisory basis, the compensation of our named executives officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| ANALOG DEVICES | March 13, 2024 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 19 funds |
AGAINST 27 funds |
| ANAVEX LIFE SCIENCES CORP. | June 18, 2024 | Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| ANGIODYNAMIC INC. | November 14, 2023 | Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| ANGIODYNAMICS INC. | November 14, 2023 | Approval of an amendment to, among other things, increase the number of shares available for issuance under the AngioDynamics, Inc. 2020 Equity Incentive Plan Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| ANI PHARMACEUTICALS INC. | May 21, 2024 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 13 funds |
| ANI PHARMACEUTICALS INC. | May 21, 2024 | To approve the compensation of the Company's named executive officers, on an advisory basis; Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 13 funds |
| ANNALY CAPITAL MANAGEMENT INC. | May 15, 2024 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 7 funds |
| ANNEXON INC. | June 5, 2024 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| ANSYS INC. | June 7, 2024 | Advisory Approval of the Compensation of Our Named Executive Officers Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 27 funds |
| ANTERIX INC. | August 8, 2023 | To approve the Anterix Inc. 2023 Stock Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| ANTERIX INC. | August 8, 2023 | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| ANTERO MIDSTREAM CORP. | June 5, 2024 | To approve the Amended and Restated Antero Midstream Corporation Long Term Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 10 funds |
| ANTERO RESOURCES CORP. | June 5, 2024 | Class II Nominees: Jacqueline C. Mutschler Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 7 funds |
| ANTERO RESOURCES CORP. | June 5, 2024 | Class II Nominees: W. Howard Keenan, Jr. Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 7 funds |
| ANTERO RESOURCES CORP. | June 5, 2024 | To approve the Amended and Restated Antero Resources Corporation 2020 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| APA CORP. | May 23, 2024 | Advisory Vote to Approve Compensation of APA's Named Executive Officers Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 15 funds |
| APA GROUP | October 26, 2023 | Approve Grant of Performance Rights to Adam Watson Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| APOGEE THERAPEUTICS INC. | June 5, 2024 | Approval of the grant of options to purchase 100,000 shares of the Company's common stock to a director, Mark C. McKenna. Compensation |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| APPLE HOSPITALITY REIT INC. | May 23, 2024 | Approval of the Apple Hospitality REIT, Inc. 2024 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 10 funds |
| APPLIED INDUSTRIAL TECHNOLOGIES INC. | October 24, 2023 | Approval of the 2023 Long-Term Performance Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| APTIV PLC | April 24, 2024 | Proposal to re-appoint auditors, ratify independent public accounting firm and authorize the directors to determine the fees paid to the auditors. Audit-related |
Board | For | AGAINST 20 funds |
FOR 18 funds |
| ARAMARK | January 30, 2024 | To hold a non-binding advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ARBUTUS BIOPHARMA CORP. | May 22, 2024 | To approve an amendment to the Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended, to (a) increase the aggregate number of common shares authorized for issuance thereunder by 9,500,000 common shares and (b) increase the aggregate number of common shares that may be issued pursuant to incentive stock options granted thereunder by 9,500,000 common shares; Compensation |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| ARBUTUS BIOPHARMA CORP. | May 22, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 8 funds |
| ARCH CAPITAL GROUP LTD. | May 9, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | Not determined | AGAINST 11 funds |
FOR 16 funds |
| ARCHER AVIATION INC. | June 21, 2024 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| ARCHROCK INC. | April 25, 2024 | Advisory, non-binding vote to approve the compensation provided to our Named Executive Officers for 2023 Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 11 funds |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | June 14, 2024 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 3 of the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| ARCUS BIOSCIENCES INC. | June 6, 2024 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 14 funds |
| ARGAN INC. | June 20, 2024 | The non-binding advisory approval of our executive compensation (the "say-on-pay" vote). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| ARKO CORP. | June 6, 2024 | Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| ARROW FINANCIAL CORP. | June 5, 2024 | To approve, on an advisory basis, a resolution relating to the 2023 executive compensation ("Say-on-Pay"). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| ARTHUR J. GALLAGHER & CO. | May 7, 2024 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 17 funds |
| ARTIVION INC. | May 14, 2024 | To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| ARVINAS INC. | May 29, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| ASSETMARK FINANCIAL HOLDINGS INC. | May 20, 2024 | Company Proposal - Approval of the Amended and Restated AssetMark Financial Holdings, Inc. 2019 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| ASSURED GUARANTY LTD. | May 2, 2024 | Advisory vote on the compensation paid to the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| ASSURED GUARANTY LTD. | May 2, 2024 | Approval of the Assured Guaranty Ltd. 2024 Long-Term Incentive Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| ASTRANA HEALTH INC. | June 12, 2024 | To approve the Company's 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 10 funds |
Page 1 of 15 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.